Market Overview

Benzinga's Top Downgrades

Share:
Related ABT
Earnings Beat Propels Abbott Laboratories To New All-Time High
Abbott Tops Q1 Expectations
A Dividend Growth Leaders Portfolio With A 17.5% Dividend Growth Rate (Seeking Alpha)
Related LLTC
Earnings Scheduled For April 14, 2015
Benzinga's M&A Chatter for Wednesday March 4, 2015

Analysts at Raymond James downgraded Abbott Laboratories (NYSE: ABT) from “outperform” to “market perform.” Abbott's shares closed at $69.04 yesterday. Abbott's trailing-twelve-month ROA is 8.67%.

Analysts at Nomura downgraded Linear Technology (NASDAQ: LLTC) from “buy” to “neutral.” Linear Technology's shares closed at $32.22 yesterday. Linear Technology's PEG ratio is 4.54.

Analysts at Stephens downgraded Halliburton Company (NYSE: HAL) from “overweight” to “equal weight.” Halliburton's shares closed at $35.32 yesterday. Halliburton's trailing-twelve-month profit margin is 10.66%.

Goldman Sachs downgraded St. Jude Medical (NYSE: STJ) from “buy” to “neutral.” St. Jude Medical's shares closed at $40.85 yesterday. St. Jude Medical's trailing-twelve-month ROE is 17.25%.

Latest Ratings for ABT

DateFirmActionFromTo
Apr 2015BarclaysMaintainsEqual-weight
Apr 2015JP MorganMaintainsNeutral
Mar 2015JefferiesMaintainsHold

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (ABT + HAL)

Around the Web, We're Loving...